Institute for Evidence-Based Healthcare, Bond University, Gold Coast, Australia.
Bond Business School, Bond University, Gold Coast, Australia.
PLoS One. 2020 Oct 26;15(10):e0240985. doi: 10.1371/journal.pone.0240985. eCollection 2020.
We examined the effect of 'labels' versus 'descriptions' across four asymptomatic health conditions: pre-diabetes, pre-hypertension, mild hyperlipidaemia, and chronic kidney disease stage 3A, on participants' intentions to pursue further tests. There were four secondary objectives: 1) assessing confidence and satisfaction in their intention to test further; 2) revealing psychological drivers affecting intentions; 3) exploring whether intentions, confidence and satisfaction differ by label vs. description and health condition; and 4) producing a perceptual map of illnesses by label condition.
Practitioner validated health-related scenarios were used. Two variants of each condition were developed. Participants were recruited through Qualtrics from Australia, Ireland and Canada and randomly assigned two 'labelled' or two 'descriptive' scenarios.
There was no significant difference in intentions to test between label and description conditions (95% CI -0.76 to 0.33 points, p = 0.4). Confidence and satisfaction were both positively associated with intentions: regression coefficient (β) for confidence β = 0.58 points (95% CI 0.49 to 0.68, p < .001) and for satisfaction 0.67 points (95% CI 0.57 to 0.77, p < .001). Predisposition to seek healthcare (β = 0.72; 95% CI 0.47 to 0.98), attributing illness to bad luck (β = -0.16 points; 95% CI -0.3 to -0.02), and concern about the health condition (β = 0.51; 95% CI 0.38 to 0.65) also significantly predicted intentions.
Unlike studies investigating symptomatic illnesses, the disease label effect on behavioural intentions was not supported suggesting that reducing demand for medical services for borderline cases cannot be achieved by labelling. The average intention to test score was higher in this sample than previous symptomatic health-related studies and there was a positive relationship between increased intentions and confidence/satisfaction in one's decision. Exploratory insights suggested perceptions of the four labelled asymptomatic illnesses all shifted toward greater levels of dread and concern compared to their respective description condition.
ACTRN12618000392268.
我们研究了在四个无症状健康状况(糖尿病前期、高血压前期、轻度血脂异常和 3A 期慢性肾脏病)中,“标签”与“描述”对参与者进一步检测意向的影响。有四个次要目标:1)评估对进一步检测的意向的信心和满意度;2)揭示影响意向的心理驱动因素;3)探索意向、信心和满意度是否因标签与描述以及健康状况而异;4)通过标签条件生成疾病感知图。
使用经过从业者验证的与健康相关的场景。为每个条件开发了两个变体。参与者通过 Qualtrics 从澳大利亚、爱尔兰和加拿大招募,并随机分配到两个“标记”或两个“描述”场景。
标签和描述条件下的检测意向无显著差异(95%CI-0.76 至 0.33 点,p=0.4)。信心和满意度均与意向呈正相关:信心的回归系数(β)为 0.58 点(95%CI 0.49 至 0.68,p<.001),满意度为 0.67 点(95%CI 0.57 至 0.77,p<.001)。寻求医疗保健的倾向(β=0.72;95%CI 0.47 至 0.98)、将疾病归因于运气不佳(β=-0.16 点;95%CI-0.3 至-0.02)和对健康状况的担忧(β=0.51;95%CI 0.38 至 0.65)也显著预测了意向。
与研究症状性疾病的研究不同,疾病标签对行为意向的影响并未得到支持,这表明不能通过标签来减少对边缘病例的医疗服务需求。与之前与症状相关的健康研究相比,该样本的平均检测意向评分更高,并且意向增加与对决策的信心/满意度之间呈正相关。探索性分析表明,与各自的描述条件相比,对四个标记的无症状疾病的感知都朝着更大程度的恐惧和担忧转变。
ACTRN12618000392268。